As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: August 12, 2017
by Women’s Health:
New research has found that the images on a person’s Instagram can indicate whether they’re suffering from depression.
The study – published in the journal EPJ Data Science – examined 43,950 photos taken from the feeds of 166 participants, nearly half of which reported being depressed in the last three years.
Their results showed that depressed individuals were more likely to post images that were bluer, greyer and darker than those who were not.
“In other words, people suffering from depression were more likely to favour a filter that literally drained all the colour out of the images they wanted to share,” wrote the authors.
They also found that the filter of choice for those suffering depression tended to be Inkwell – which turns images black and white.
Further, depressed individuals were more likely to post photos with faces, but they tended to post fewer faces per photo than healthy people’s Instagram feeds.
“This points toward a new method for early screening of depression and other emerging mental illnesses,” says co-study-author Chris Danforth, a professor at the University of Vermont, in a press release. “This algorithm can sometimes detect depression before a clinical diagnosis is made. … This study is not yet a diagnostic test, not by a long shot, but it is a proof of concept of a new way to help people.”
Napping for an hour in the afternoon may provide a mental boost for older adults, a new study suggests. This extra daytime sleep was linked to improved memory and ability to think clearly...
The results of recent trials that tested much-anticipated Alzheimer’s disease drugs dashed the hopes of patients with the debilitating condition. The most recent disappointment came from the large trial for solanezumab, by Eli Lilly, announced last...
Treatment with the antibiotic Rocephin (ceftriaxone) may restore brain function in areas affected by Alzheimer’s disease, according to new research. The study, “Mapping Synaptic Glutamate Transporter Dysfunction In Vivo To Regions Surrounding Aβ...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.